Versant Capital Management, Inc Royalty Pharma PLC Transaction History
Versant Capital Management, Inc
- $454 Million
- Q4 2024
A detailed history of Versant Capital Management, Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Versant Capital Management, Inc holds 120 shares of RPRX stock, worth $3,609. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120
Previous 874
86.27%
Holding current value
$3,609
Previous $24,000
87.5%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding RPRX
# of Institutions
410Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.24 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1.13 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$692 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$485 Million0.35% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$366 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...